Background: Patients with cirrhosis are at high risk for developing liver cancer/hepatocellular carcinoma (HCC). Adherence to HCC surveillance guidelines with abdominal ultrasound (US) and alpha-fetoprotein (AFP) blood test every six months improves detection of HCC in the early stages, providing opportunities for potentially curative treatments. However, the guidelines are underused, and literature shows that less than 10% of cirrhotic patients undergo surveillance in primary care settings. Objectives: This DNP project aimed to assess the effectiveness of implementing the quality improvement (QI) measures and electronic medical record (EMR) alerts along with patient education to improve HCC surveillance rates for cirrhosis patients in comm...
Infection with Hepatitis C Virus (HCV) is a grave health concern it is also a major cause of liver r...
OBJECTIVES: Surveillance of cirrhotic patients for early detection of hepatocellular carcinoma, base...
Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with hepatitis B...
Background: Patients with cirrhosis are at high risk for developing liver cancer/hepatocellular carc...
<p><b><i>Objective:</i></b> Hepatocellular carcinoma (HCC) is the second most common cause of cance...
: Patients with cirrhosis are advised to undergo hepatocellular carcinoma (HCC) surveillance every 6...
Hepatocellular carcinoma (HCC) is a common complication of cirrhosis. The incidence of HCC is rising...
OBJECTIVES: Surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma (HCC)...
The aim of this study is to examine the acceptability and effectiveness of a nurse-led hepatocellula...
Background: Surveillance for hepatocellular carcinoma (HCC) is recommended in patients with cirrhosi...
Aim: Hepatocellular carcinoma (HCC) is a common cancer worldwide, especially in Asia, with high mort...
Surveillance for hepatocellular carcinoma (HCC) is considered a standard of care for patients with c...
To estimate hepatocellular carcinoma surveillance in the Medicaid cirrhotic population
Background: The minimal number of hepatocellular carcinoma (HCC) patients diagnosed through surveill...
A large proportion of patients with cirrhosis are seen only by their primary care provider (PCP). Su...
Infection with Hepatitis C Virus (HCV) is a grave health concern it is also a major cause of liver r...
OBJECTIVES: Surveillance of cirrhotic patients for early detection of hepatocellular carcinoma, base...
Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with hepatitis B...
Background: Patients with cirrhosis are at high risk for developing liver cancer/hepatocellular carc...
<p><b><i>Objective:</i></b> Hepatocellular carcinoma (HCC) is the second most common cause of cance...
: Patients with cirrhosis are advised to undergo hepatocellular carcinoma (HCC) surveillance every 6...
Hepatocellular carcinoma (HCC) is a common complication of cirrhosis. The incidence of HCC is rising...
OBJECTIVES: Surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma (HCC)...
The aim of this study is to examine the acceptability and effectiveness of a nurse-led hepatocellula...
Background: Surveillance for hepatocellular carcinoma (HCC) is recommended in patients with cirrhosi...
Aim: Hepatocellular carcinoma (HCC) is a common cancer worldwide, especially in Asia, with high mort...
Surveillance for hepatocellular carcinoma (HCC) is considered a standard of care for patients with c...
To estimate hepatocellular carcinoma surveillance in the Medicaid cirrhotic population
Background: The minimal number of hepatocellular carcinoma (HCC) patients diagnosed through surveill...
A large proportion of patients with cirrhosis are seen only by their primary care provider (PCP). Su...
Infection with Hepatitis C Virus (HCV) is a grave health concern it is also a major cause of liver r...
OBJECTIVES: Surveillance of cirrhotic patients for early detection of hepatocellular carcinoma, base...
Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with hepatitis B...